
Continuous vs Intermittent β-Lactam Infusions in Sepsis Patients
What was it? Multicenter, open-label, randomized controlled trial (BLING III) evaluating continuous versus intermittent infusion of β-lactam antibiotics (piperacillin-tazobactam or meropenem) in critically ill patients with sepsis, conducted across 104 intensive care units (ICUs) in Australia, Belgium, France, Malaysia, New Zealand, Sweden, and the United Kingdom. The Devil in the Details! 7,031 patients analyzed (3,498…